Cargando…

Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms

PURPOSE: To perform a comprehensive validation of plans generated on a preconfigured Halcyon 2.0 with preloaded beam model, including evaluations of new features and implementing the patient specific quality assurance (PSQA) process with multiple detectors. METHODS: A total of 56 plans were generate...

Descripción completa

Detalles Bibliográficos
Autores principales: Laugeman, Eric, Heermann, Ana, Hilliard, Jessica, Watts, Michael, Roberson, Marshia, Morris, Robert, Goddu, Sreekrishna, Sethi, Abhishek, Zoberi, Imran, Kim, Hyun, Mutic, Sasa, Hugo, Geoffrey, Cai, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386180/
https://www.ncbi.nlm.nih.gov/pubmed/32368862
http://dx.doi.org/10.1002/acm2.12881
_version_ 1783563905245642752
author Laugeman, Eric
Heermann, Ana
Hilliard, Jessica
Watts, Michael
Roberson, Marshia
Morris, Robert
Goddu, Sreekrishna
Sethi, Abhishek
Zoberi, Imran
Kim, Hyun
Mutic, Sasa
Hugo, Geoffrey
Cai, Bin
author_facet Laugeman, Eric
Heermann, Ana
Hilliard, Jessica
Watts, Michael
Roberson, Marshia
Morris, Robert
Goddu, Sreekrishna
Sethi, Abhishek
Zoberi, Imran
Kim, Hyun
Mutic, Sasa
Hugo, Geoffrey
Cai, Bin
author_sort Laugeman, Eric
collection PubMed
description PURPOSE: To perform a comprehensive validation of plans generated on a preconfigured Halcyon 2.0 with preloaded beam model, including evaluations of new features and implementing the patient specific quality assurance (PSQA) process with multiple detectors. METHODS: A total of 56 plans were generated in Eclipse V15.6 (Varian Medical System) with a preconfigured Halcyon treatment machine. Ten plans were developed via the AAPM TG‐119 test suite with both IMRT and VMAT techniques. 34 clinically treated plans using C‐arm LINAC from 24 patients were replanned on Halcyon using IMRT or VMAT techniques for a variety of sites including: brain, head and neck, lung, breast, abdomen, and pelvis. Six of those plans were breast VMAT plans utilizing the extended treatment field technique available with Halcyon 2.0. The dynamically flattened beam (DFB), another new feature on Halcyon 2.0, was also used for an AP/PA spine and four field box pelvis, as well as ten 3D breast plans. All 56 plans were measured with an ion chamber (IC), film, portal dosimetry (PD), ArcCHECK, and Delta4. Tolerance and action limits were calculated and compared to the recommendations of TG‐218. RESULTS: TG‐119 IC and film confidence limits met those set by the task group, except for IMRT target point dose. Forty‐four of 46 clinical plans were within 3% for IC measurements. Average gamma passing rates with 3% dose difference and 2mm distance‐to‐agreement for IMRT/VMAT plans were: Film – 96.8%, PD – 99.9%, ArcCHECK – 99.1%, and Delta4 – 99.2%. Calculated action limits were: Film – 86.3%, PD – 98.4%, ArcCHECK – 96.1%, and Delta4 – 95.7%. Extended treatment field technique was fully validated and 3D plans with DFB had similar results to IMRT/VMAT plans. CONCLUSION: Halcyon plan deliveries were verified with multiple measurement devices. New features of Halcyon 2.0 were also validated. Traditional PSQA techniques and process specific tolerance and action limits were successfully implemented.
format Online
Article
Text
id pubmed-7386180
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-73861802020-07-30 Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms Laugeman, Eric Heermann, Ana Hilliard, Jessica Watts, Michael Roberson, Marshia Morris, Robert Goddu, Sreekrishna Sethi, Abhishek Zoberi, Imran Kim, Hyun Mutic, Sasa Hugo, Geoffrey Cai, Bin J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: To perform a comprehensive validation of plans generated on a preconfigured Halcyon 2.0 with preloaded beam model, including evaluations of new features and implementing the patient specific quality assurance (PSQA) process with multiple detectors. METHODS: A total of 56 plans were generated in Eclipse V15.6 (Varian Medical System) with a preconfigured Halcyon treatment machine. Ten plans were developed via the AAPM TG‐119 test suite with both IMRT and VMAT techniques. 34 clinically treated plans using C‐arm LINAC from 24 patients were replanned on Halcyon using IMRT or VMAT techniques for a variety of sites including: brain, head and neck, lung, breast, abdomen, and pelvis. Six of those plans were breast VMAT plans utilizing the extended treatment field technique available with Halcyon 2.0. The dynamically flattened beam (DFB), another new feature on Halcyon 2.0, was also used for an AP/PA spine and four field box pelvis, as well as ten 3D breast plans. All 56 plans were measured with an ion chamber (IC), film, portal dosimetry (PD), ArcCHECK, and Delta4. Tolerance and action limits were calculated and compared to the recommendations of TG‐218. RESULTS: TG‐119 IC and film confidence limits met those set by the task group, except for IMRT target point dose. Forty‐four of 46 clinical plans were within 3% for IC measurements. Average gamma passing rates with 3% dose difference and 2mm distance‐to‐agreement for IMRT/VMAT plans were: Film – 96.8%, PD – 99.9%, ArcCHECK – 99.1%, and Delta4 – 99.2%. Calculated action limits were: Film – 86.3%, PD – 98.4%, ArcCHECK – 96.1%, and Delta4 – 95.7%. Extended treatment field technique was fully validated and 3D plans with DFB had similar results to IMRT/VMAT plans. CONCLUSION: Halcyon plan deliveries were verified with multiple measurement devices. New features of Halcyon 2.0 were also validated. Traditional PSQA techniques and process specific tolerance and action limits were successfully implemented. John Wiley and Sons Inc. 2020-05-05 /pmc/articles/PMC7386180/ /pubmed/32368862 http://dx.doi.org/10.1002/acm2.12881 Text en © 2020 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Laugeman, Eric
Heermann, Ana
Hilliard, Jessica
Watts, Michael
Roberson, Marshia
Morris, Robert
Goddu, Sreekrishna
Sethi, Abhishek
Zoberi, Imran
Kim, Hyun
Mutic, Sasa
Hugo, Geoffrey
Cai, Bin
Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms
title Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms
title_full Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms
title_fullStr Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms
title_full_unstemmed Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms
title_short Comprehensive validation of halcyon 2.0 plans and the implementation of patient specific QA with multiple detector platforms
title_sort comprehensive validation of halcyon 2.0 plans and the implementation of patient specific qa with multiple detector platforms
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386180/
https://www.ncbi.nlm.nih.gov/pubmed/32368862
http://dx.doi.org/10.1002/acm2.12881
work_keys_str_mv AT laugemaneric comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms
AT heermannana comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms
AT hilliardjessica comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms
AT wattsmichael comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms
AT robersonmarshia comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms
AT morrisrobert comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms
AT goddusreekrishna comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms
AT sethiabhishek comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms
AT zoberiimran comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms
AT kimhyun comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms
AT muticsasa comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms
AT hugogeoffrey comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms
AT caibin comprehensivevalidationofhalcyon20plansandtheimplementationofpatientspecificqawithmultipledetectorplatforms